Consolidated CDER/CBER INDs renumbered
The Center for Drug Evaluation & Research will assign new numbers to a group of INDs that were transferred from the Center for Biologics Evaluation & Research in 2003. The 2003 consolidation of the two centers created INDs with duplicate numbers (1"The Pink Sheet" Sept. 15, 2003, p. 14). To resolve the problem, INDs numbered below 14,000 submitted to CDER before the consolidation will be given new numbers by adding 80,000 to the original IND number...
You may also be interested in...
FDA is actively recruiting to replace 20 staffers who have left the Center for Biologics Evaluation & Research since plans to consolidate with CDER were announced a year ago
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
The Minnesota-based health care system announced the formation of Anumana Inc. to commercialize artificial intelligence-enabled algorithms and Lucem Health to curate data collected from remote monitoring devices.